Team:HZAU-China/Project/The design of experiment

From 2013.igem.org

(Difference between revisions)
 
(12 intermediate revisions not shown)
Line 38: Line 38:
ul.menu:after{content:"";display:block;height:0;clear:both;visibility:hidden;}
ul.menu:after{content:"";display:block;height:0;clear:both;visibility:hidden;}
ul.menu,
ul.menu,
-
ul.menu ul {padding:0;margin:0;list-style:none;position:;width:220px;background:#ddd;font-family:arial, sans-serif;}
+
ul.menu ul {padding:0;margin:0;list-style:none;position:;width:220px;background:#d3f18c;font-family:arial, sans-serif;}
ul.menu {z-index:100;padding:10px;margin:0 auto;}
ul.menu {z-index:100;padding:10px;margin:0 auto;}
ul.menu ul {z-index:50;
ul.menu ul {z-index:50;
Line 50: Line 50:
ul.menu > li {margin-top:2px;font-size:12px;}
ul.menu > li {margin-top:2px;font-size:12px;}
ul.menu > li a {font:normal 16px/29px arial, sans-serif;color:#fff;text-decoration:none;}
ul.menu > li a {font:normal 16px/29px arial, sans-serif;color:#fff;text-decoration:none;}
-
ul.menu label.open {display:block;background:#c00 no-repeat 170px 12px;line-height:30px;position:relative;z-
+
ul.menu label.open {display:block;background:#517b1f no-repeat 170px 12px;line-height:30px;position:relative;z-
-
 
+
index:100;font:normal 12px/30px arial, sans-serif;color:#fff;border-radius:10px 10px 0 0;}
index:100;font:normal 12px/30px arial, sans-serif;color:#fff;border-radius:10px 10px 0 0;}
-
ul.menu label.open b {color:#ff0;}
+
ul.menu span {display:block;background:#517b1f;line-height:30px;position:relative;z-index:100;font-size: 16px;padding-left:10px;}
-
ul.menu span {display:block;background:#c00;line-height:30px;position:relative;z-index:100;font-size: 16px;padding-left:10px;}
+
ul.menu label img {position:absolute;left:0;top:0;width:100%;height:30px;}
ul.menu label img {position:absolute;left:0;top:0;width:100%;height:30px;}
ul.menu ul li {margin-top:-30px;
ul.menu ul li {margin-top:-30px;
Line 63: Line 61:
transition: 0.5s;
transition: 0.5s;
}
}
-
ul.menu ul li a {display:block;font:normal 16px/29px arial, sans-serif;color:#000;background:#ccc;}
+
ul.menu ul li a {display:block;font:normal 16px/29px arial, sans-serif;color:#000;background:#b3e24b;}
-
ul.menu ul li a:hover {background:#ddd;}
+
ul.menu ul li a:hover {background:#d3f18c;}
ul.menu input {position:absolute;left:-9999px;}
ul.menu input {position:absolute;left:-9999px;}
ul.menu li input:checked + label {background:#069;}
ul.menu li input:checked + label {background:#069;}
-
ul.menu li input:checked ~ ul {background:#ccc;padding-bottom:10px;}
+
ul.menu li input:checked ~ ul {background:#b3e24b;padding-bottom:10px;}
ul.menu li input:checked ~ ul li {margin-top:0;}
ul.menu li input:checked ~ ul li {margin-top:0;}
ul.menu label.close {display:block;width:200px;height:30px;background:transparent url("/jscss/demoimg/201208/u-arrow.gif")  
ul.menu label.close {display:block;width:200px;height:30px;background:transparent url("/jscss/demoimg/201208/u-arrow.gif")  
Line 77: Line 75:
ul.menu input.close:checked ~ ul li {margin-top:-30px;}
ul.menu input.close:checked ~ ul li {margin-top:-30px;}
</style>
</style>
 +
<script>
<script>
Line 98: Line 97:
         <ul class="menu">
         <ul class="menu">
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project"><span>Overview</span></a></li>
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project"><span>Overview</span></a></li>
-
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/The innovation of HZAU-iGEM Team"><span>The innovation of HZAU-iGEM Team</span></a></li>  
+
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/The innovation of HZAU-iGEM Team"><span>The innovation of HZAU-iGEM Team</span></a></li>
 +
        <li><a href="https://2013.igem.org/Team:HZAU-China/Project/The design of experiment"><span style="font-size:19px;color=#fff;">The design of experiment</span></a></li>  
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Rabies"><span>Rabies</span></a></li>
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Rabies"><span>Rabies</span></a></li>
-
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Flea and Yersinia pestis"><span>Flea and Yersinia pestis</span></a></li>
+
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Flea and Yersinia pestis"><span><i>Flea and Yersinia pestis<i></span></a></li>
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Bacterial Spores as Vaccine Vehicles"><span>Bacterial Spores as Vaccine Vehicles</span></a></li>
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Bacterial Spores as Vaccine Vehicles"><span>Bacterial Spores as Vaccine Vehicles</span></a></li>
-
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Bacillus subtilis as Probiotics"><span>Bacillus subtilis as Probiotics</span></a></li>  
+
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Bacillus subtilis as Probiotics"><span><i>Bacillus subtilis</i> as Probiotics</span></a></li>  
-
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Antimicrobial Peptides"><span>Antimicrobial Peptides</span></a></li>  
+
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Antimicrobial Peptides"><span>Antimicrobial Peptides</span></a></li>
-
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/The design of experiment"><span style="font-size:19px;color=#fff;">The design of experiment</span></a></li>  
+
         <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Methods for rearing flea"><span>Methods for rearing flea</span></a></li>
-
       
+
       </body>
       </body>
     </div>
     </div>
Line 115: Line 114:
       <p><br></p>
       <p><br></p>
   
   
-
       <p style="font-size:16px;font-family:arial, sans-serif;">We chose Bacillus subtilis as our chassis, because it has some characters that are very suitable for a “safe moving vaccine factory”.</p>
+
       <p style="font-size:16px;font-family:arial, sans-serif;">We chose <i> Bacillus subtilis </i> as our chassis, because it has some characters that are very suitable for a “safe moving vaccine factory”.</p>
       <p style="font-size:16px;font-family:arial, sans-serif;">The following are the reasons:</p>
       <p style="font-size:16px;font-family:arial, sans-serif;">The following are the reasons:</p>
-
       <p style="font-size:16px;font-family:arial, sans-serif;">1.Bacillus subtilis can form biofilm that we think is important for being transferred from fleas to dogs.</p>
+
       <p style="font-size:16px;font-family:arial, sans-serif;">1.<i> Bacillus subtilis </i> can form biofilm that we think is important for being transferred from fleas to dogs.</p>
-
       <p style="font-size:16px;font-family:arial, sans-serif;">2.Bacillus subtilis has many advantages as a tool for vaccine vector.</p>
+
       <p style="font-size:16px;font-family:arial, sans-serif;">2.<i> Bacillus subtilis </i> has many advantages as a tool for vaccine vector.</p>
-
       <p style="font-size:16px;font-family:arial, sans-serif;">3.Bacillus subtilis has already been used as probiotics and maybe exists in the internal environment of fleas.</p>
+
       <p style="font-size:16px;font-family:arial, sans-serif;">3.<i> Bacillus subtilis </i> has already been used as probiotics and maybe exists in the internal environment of fleas.</p>
        
        
       <p style="font-size:16px;font-family:arial, sans-serif;">The experiment designs and genetic circuit are as follows:</p>
       <p style="font-size:16px;font-family:arial, sans-serif;">The experiment designs and genetic circuit are as follows:</p>
       <h3>1.For the vaccine question</h3>
       <h3>1.For the vaccine question</h3>
-
       <p style="font-size:16px;font-family:arial, sans-serif;">In order to know whether our vaccine can activate the immunity system of dogs, we used B.subtilis as vaccine vector to express secreted glycoprotein. Five proteins are present in rabies virus particles: nucleoprotein, phosphoprotein, matrixprotein, glycoprotein and RNA-dependent RNA polymerase. Because of containing the neutralizing epitopes which are the targets of vaccine-induced immunity, the glycoprotein can stimulate the organism to produce antibody against Rabies.</p>
+
       <p style="font-size:16px;font-family:arial, sans-serif;">In order to know whether our vaccine can activate the immunity system of dogs, we used <i>bacillus subtilis</i> as vaccine vector to express secreted glycoprotein. Five proteins are present in rabies virus particles: nucleoprotein, phosphoprotein, matrixprotein, glycoprotein and RNA-dependent RNA polymerase. Because of containing the neutralizing epitopes which are the targets of vaccine-induced immunity, the glycoprotein can stimulate the organism to produce antibody against Rabies.</p>
<p  style="text-align:center;"><a><img width="" src="https://static.igem.org/mediawiki/igem.org/3/3e/5.1_%E5%89%AF%E6%9C%AC.png" ></a></br></p>
<p  style="text-align:center;"><a><img width="" src="https://static.igem.org/mediawiki/igem.org/3/3e/5.1_%E5%89%AF%E6%9C%AC.png" ></a></br></p>
-
<p style="font-size:13px;font-family:arial, sans-serif;">Fig. 1. shows the genetic circuit of the device secreting Rabies virus strain ERA glycoprotein in bacillus subtilis. Part K541501 contains constitutive promoter veg(K143012), Ribosome Binding Site spoVG(K143021) and signal peptide SacB. iGEM11_FAGEM designed this part and it worked very good in B.subtilis. Part K1228002 is designed by our team. It is a rabies virus strain ERA glycoprotein coding sequence. The glycoprotein is the main protective antigen of rabies virus which can induce the body to produce neutralizing antibody.</p>
+
<p style="font-size:13px;font-family:arial, sans-serif;">Fig. 1. shows the genetic circuit of the device secreting Rabies virus strain ERA glycoprotein in <i>bacillus subtilis</i>. Part K541501 contains constitutive promoter veg(K143012), Ribosome Binding Site spoVG(K143021) and signal peptide SacB. iGEM11_FAGEM designed this part and it worked very good in <i>bacillus subtilis</i>. Part K1228002 is designed by our team. It is a rabies virus strain ERA glycoprotein coding sequence. The glycoprotein is the main protective antigen of rabies virus which can induce the body to produce neutralizing antibody.</p>
       <h3>2.For the moving question</h3>
       <h3>2.For the moving question</h3>
-
       <p style="font-size:16px;font-family:arial, sans-serif;">In order to know whether the modified B.subtilis can be regurgitated by flea, two experiments are designed One is to feed flea using modified B.subtilis that can express GFP. This design is to know whether the flea can eat B.subtilis that colonizes in the proventricular. Another goal is to test whether the bacteria can make flea vomit.</p>
+
       <p style="font-size:16px;font-family:arial, sans-serif;">In order to know whether the modified B.subtilis can be regurgitated by flea, two experiments are designed One is to feed flea using modified B.subtilis that can express GFP. This design is to know whether the flea can eat <i>bacillus subtilis</i> that colonizes in the proventricular. Another goal is to test whether the bacteria can make flea vomit.</p>
<p  style="text-align:center;"><a><img width="" src="https://static.igem.org/mediawiki/igem.org/7/71/5_2_%E5%89%AF%E6%9C%AC.png" ></a></br></p>
<p  style="text-align:center;"><a><img width="" src="https://static.igem.org/mediawiki/igem.org/7/71/5_2_%E5%89%AF%E6%9C%AC.png" ></a></br></p>
 +
<p style="font-size:13px;font-family:arial, sans-serif;">Fig. 2.shows the genetic circuit of GFP device. Promoter Veg is a constitutive promoter that constitutively expresses the P43 protein in <i>bacillus subtilis</i> .It was designed by iGEM08_Imperial_college. The rest is a GFP generator designed by Igem08_UNIPV-Pavia.</p>
       <p style="font-size:16px;font-family:arial, sans-serif;"><b>Notice</b>: We stopped this experiment because of safety reason. We haven’t found safe flea to achieve this experiment. Although we currently cannot provide experimental data to solve this question, we are ready to provide a complete experiment protocol and the devices needed in the experiment. In the future, when we make sure it is safe enough to release flea, we will cooperate with professional institutes to finish it.</p>
       <p style="font-size:16px;font-family:arial, sans-serif;"><b>Notice</b>: We stopped this experiment because of safety reason. We haven’t found safe flea to achieve this experiment. Although we currently cannot provide experimental data to solve this question, we are ready to provide a complete experiment protocol and the devices needed in the experiment. In the future, when we make sure it is safe enough to release flea, we will cooperate with professional institutes to finish it.</p>
       <h3>3.For the safety question</h3>
       <h3>3.For the safety question</h3>
-
       <p style="font-size:16px;font-family:arial, sans-serif;">A certain number of infectious bacteria carried by flea will cause potential risks which are hard to control, so broad spectrum Antimicrobial Peptides have been designed as secreted protein to kill those infectious bacteria such as Yersinia pestis.</p>
+
       <p style="font-size:16px;font-family:arial, sans-serif;">A certain number of infectious bacteria carried by flea will cause potential risks which are hard to control, so broad spectrum Antimicrobial Peptides have been designed as secreted protein to kill those infectious bacteria such as <i>Yersinia pestis</i>.</p>
 +
<p  style="text-align:center;"><a><img width="" src="https://static.igem.org/mediawiki/igem.org/5/55/5_3.png" ></a></br></p>
 +
<p style="font-size:13px;font-family:arial, sans-serif;">Fig. 3.a shows the genetic circuit of the device secreting Human Lysozyme in <i>bacillus subtilis</i>. Part K541501 contains constitutive promoter veg(K143012), Ribosome Binding Site spoVG(K143021) and signal peptide SacB. iGEM11_FAGEM designed this part and it worked very good in B.subtilis. Part K122800 was designed by our team. Human lysozyme (hLZ) exhibits microbicidal activity to various degrees against several bacterial strains.
 +
</p>
 +
<p style="font-size:13px;font-family:arial, sans-serif;">Fig. 3.b shows the genetic circuit of the device secreting Lactoferrin in <i>B.subtilis</i>. This protein has a broad spectrum of anti-infection and anti-inflammatory function.
 +
</p>
 +
 
 +
<h3>Reference</h3>
 +
 
 +
<p style="font-size:16px;font-family:arial, sans-serif;">1. LUÍS C.S. FERREIRA, RITA C.C. FERREIRA1 and WOLFGANG SCHUMANN. <i>bacillus subtilis</i> as a tool for vaccine development: from antigen factories to delivery vectors. Anais da academia Brasileira de Ciências, 2005;77(1): 113-124.</p>
 +
 
 +
<p style="font-size:16px;font-family:arial, sans-serif;">2. Morimoto K, Hooper DC, Spitsin S, et al. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol, 1999; 73, 510‐8.</p>
     </div>
     </div>

Latest revision as of 04:20, 28 September 2013


The design of experiment


We chose Bacillus subtilis as our chassis, because it has some characters that are very suitable for a “safe moving vaccine factory”.

The following are the reasons:

1. Bacillus subtilis can form biofilm that we think is important for being transferred from fleas to dogs.

2. Bacillus subtilis has many advantages as a tool for vaccine vector.

3. Bacillus subtilis has already been used as probiotics and maybe exists in the internal environment of fleas.

The experiment designs and genetic circuit are as follows:

1.For the vaccine question

In order to know whether our vaccine can activate the immunity system of dogs, we used bacillus subtilis as vaccine vector to express secreted glycoprotein. Five proteins are present in rabies virus particles: nucleoprotein, phosphoprotein, matrixprotein, glycoprotein and RNA-dependent RNA polymerase. Because of containing the neutralizing epitopes which are the targets of vaccine-induced immunity, the glycoprotein can stimulate the organism to produce antibody against Rabies.


Fig. 1. shows the genetic circuit of the device secreting Rabies virus strain ERA glycoprotein in bacillus subtilis. Part K541501 contains constitutive promoter veg(K143012), Ribosome Binding Site spoVG(K143021) and signal peptide SacB. iGEM11_FAGEM designed this part and it worked very good in bacillus subtilis. Part K1228002 is designed by our team. It is a rabies virus strain ERA glycoprotein coding sequence. The glycoprotein is the main protective antigen of rabies virus which can induce the body to produce neutralizing antibody.

2.For the moving question

In order to know whether the modified B.subtilis can be regurgitated by flea, two experiments are designed One is to feed flea using modified B.subtilis that can express GFP. This design is to know whether the flea can eat bacillus subtilis that colonizes in the proventricular. Another goal is to test whether the bacteria can make flea vomit.


Fig. 2.shows the genetic circuit of GFP device. Promoter Veg is a constitutive promoter that constitutively expresses the P43 protein in bacillus subtilis .It was designed by iGEM08_Imperial_college. The rest is a GFP generator designed by Igem08_UNIPV-Pavia.

Notice: We stopped this experiment because of safety reason. We haven’t found safe flea to achieve this experiment. Although we currently cannot provide experimental data to solve this question, we are ready to provide a complete experiment protocol and the devices needed in the experiment. In the future, when we make sure it is safe enough to release flea, we will cooperate with professional institutes to finish it.

3.For the safety question

A certain number of infectious bacteria carried by flea will cause potential risks which are hard to control, so broad spectrum Antimicrobial Peptides have been designed as secreted protein to kill those infectious bacteria such as Yersinia pestis.


Fig. 3.a shows the genetic circuit of the device secreting Human Lysozyme in bacillus subtilis. Part K541501 contains constitutive promoter veg(K143012), Ribosome Binding Site spoVG(K143021) and signal peptide SacB. iGEM11_FAGEM designed this part and it worked very good in B.subtilis. Part K122800 was designed by our team. Human lysozyme (hLZ) exhibits microbicidal activity to various degrees against several bacterial strains.

Fig. 3.b shows the genetic circuit of the device secreting Lactoferrin in B.subtilis. This protein has a broad spectrum of anti-infection and anti-inflammatory function.

Reference

1. LUÍS C.S. FERREIRA, RITA C.C. FERREIRA1 and WOLFGANG SCHUMANN. bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. Anais da academia Brasileira de Ciências, 2005;77(1): 113-124.

2. Morimoto K, Hooper DC, Spitsin S, et al. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol, 1999; 73, 510‐8.